跳至主要内容
临床试验/NCT02385292
NCT02385292已完成不适用

Randomized, Controlled, Crossover, Multicenter Trial Comparing Quality of Tears Produced by Nasal Neurostimulation Versus Sham for Dry Eye

Oculeve, Inc.4 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2015年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Oculeve, Inc.
入组人数
23
试验地点
4
主要终点
Fluorescein Tear Clearance With Application

研究概览

简要总结

The objectives of this study are:

  • To compare the change in levels of tear proteins and inflammatory mediators pre and post administration between the intranasal and extranasal applications
  • To compare the goblet cell count following application between the intranasal and extranasal applications
  • To compare fluorescein tear clearance with the application of the device intranasally and extranasally applications

详细描述

In this study, subjects will participate for three study days during up to a 44 day period, consisting of a screening examination to determine eligibility on one day and study applications on two different days. There are two applications, intranasal and extranasal. Subjects will receive both applications, in random sequence, one at each of the two application days (Visit 2 and Visit 3). The two applications consist of:

  • Active intranasal device application
  • Active extranasal device application

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Bilateral dry eyes
  • Capable of providing written informed consent

排除标准

  • Chronic or recurring epistaxis (nosebleeds)
  • Blood coagulation disorder
  • Uncontrolled or poorly controlled diabetes
  • Heart or pulmonary disease
  • Females who are pregnant, planning a pregnancy or nursing

结局指标

主要结局

Fluorescein Tear Clearance With Application

时间窗: Day 1

次要结局

未报告次要终点

研究者

发起方
Oculeve, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Multicenter Trial Evaluating Quality of Tears... | 临床试验